Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer
A large review has found no difference in overall survival with fixed-duration vs ongoing ICI treatment in progression-free non –small cell lung cancer.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Hematology | Immunotherapy | Lung Cancer